Drug Channels: Key Insights on Drug Prices and Manufacturer Rebates from the New 2015 IMS Report, ims data pharma.#Ims #data #pharma

Posted On May 18 2018 by

ims data pharma DRUG DISAMBIGUATION DETAILS Spending on medicines and invoice price spending both refer to the amounts paid to distributors by their pharmacy or hospital customers. Net price spending is an estimate of the net revenues received by pharmaceutical manufacturers. It therefore reflects estimated rebates, off-invoice discounts, chargebacks, cash discounts, and other price concessions made by manufacturers to distributors, health plans and intermediaries. None of these terms, however, directly correspond to pharmacy revenues, a plan sponsor s drug costs, and national healthcare expenditures. For example: Pharmacy revenues, for example, roughly equate to IMS s spending on medicines for outpatient …


Welcome to Ajanta Pharma Limited, ims pharma.#Ims #pharma

Posted On May 18 2018 by

Branded Generics Branded Generics Business At Ajanta, we produce a comprehensive range of specialty products targeting different therapeutic segments for treatment of patients, customised to each market we are present in. We clearly understand our customer’s needs and use cutting edge technology to present innovative solutions. We identify complex areas that need innovation and commit ourselves to find a solution, within a defined time frame. We extend this thought-process to the markets we choose to enter and the capabilities we want to build. The branded generics business is spread in India and more than 30 emerging countries across Africa, CIS, …


Medical Recruitment for UK and Europe, ims pharma.#Ims #pharma

Posted On May 17 2018 by

ims pharma IMS is one of Europe s pre-eminent medical recruitment companies Healthcare and pharmaceutical research companies utilise IMS for its extensive experience and expertise in successfully recruiting across Europe. NURSE JOB WANTED IN THE UK. FOR NMC NOW POSSIBLE TO TAKE OET INSTEAD OF IELTS IMS Recruitment is a leading agency recruiting nurses for positions in the UK, Ireland and Middle East. The Nursing and Midwifery Council (NMC) has made an alternative option available for nurses and midwives, trained outside the UK, to demonstrate their English language capability. From 1 Nov 2017, The NMC will accept the Occupational English …


Over the Counter Drugs – Medication, South Africa, ims pharma.#Ims #pharma

Posted On May 17 2018 by

ims pharma 9 things to know about mental health A mental illness is when your ability to function properly is affected by negative changes in your mood, thoughts, emotions and behaviour. Most people with mental illness are not violent, only about 3 – 5% of violent acts can be attributed to people with serious mental illness. Although most people assume that mental health problems are irreversible, with proper treatment, and support, mental health patients can recover completely. Prevention is better than cure. Focus on a holistic state of wellbeing, pay attention to warning signs, consciously lower your stress levels and …


IMS 2015 Use of Medicines report: US sales reach $424, ims data pharma.#Ims #data #pharma

Posted On Mar 5 2018 by

IMS 2015 Use of Medicines report: US sales reach $424.8 billion Double-digit growth (12.2%) for the second year running The annual Use of Medicines report, from the IMS Institute for Healthcare Informatics, comes at a time when drug pricing and revenue growth has been under intensive stress. Perhaps in part for this reason, the Institute is much more careful about distinguishing between ex-manufacturer invoice pricing (which is essentially the price that wholesalers charge their customers) and what it calls “net-price spending,” which accounts for the tens of billions of dollars that pharma companies forgo through rebates, discounts and other off-invoice …


Breaking Down GlaxoSmithKline – s Billion-Dollar Wrongdoing, ims data pharma.#Ims #data #pharma

Posted On Mar 5 2018 by

Breaking Down GlaxoSmithKline s Billion-Dollar Wrongdoing What the drug company did to promote Paxil, Wellbutrin and Avandia illegally — and what it meant for patients In the largest settlement involving a pharmaceutical company, the U.S. Justice Department announced on July 2 that GlaxoSmithKline LLC will pay $3 billion in fines and plead guilty to marketing drugs for unapproved uses and failing to report drug safety information to the U.S. Food and Drug Administration (FDA). The criminal charges involved the illegal marketing of the antidepressants Paxil and Wellbutrin and the withholding of data on the health risks of the diabetes medication …


Welcome Close Up, Close-Up Internacional, ims pharma.#Ims #pharma

Posted On Mar 5 2018 by

Prescription More than 120 Information and essential Exclusive services technology More than 650 Developer of the first business Business Analyzer® Arbitration due to a breach in an agreement by IMS Health Launch of Business Analyzer ® Audits This is a solution that effectively measures the prescription results of a promotional effort, by systematically investigating the behavior of markets, therapeutic classes, molecules, products, laboratories and their trends. Targeting enables us to choose Prescribers by therapeutic market in order to target promotional activities on physicians and track the results. It enables users to measure productivity by region (District Manager and Representatives), according …


Natco Pharma locked at 20% upper circuit as partner Mylan gets USFDA nod for multiple sclerosis drug, ims pharma.#Ims #pharma

Posted On Mar 5 2018 by

Natco Pharma locked at 20% upper circuit as partner Mylan gets USFDA nod for multiple sclerosis drug Shares of Natco Pharma locked at 20 percent upper circuit on the back of USFDA approval for Glatiramer Acetate Injection. The company’s marketing partner Mylan’s has received US Food and Drug Administration (FDA) approval for Glatiramer Acetate Injection in strengths of 40 mg/mL and 20 mg/mL. The 40 mg and 20 mg strengths injections are an AP-rated, substitutable generic version of Teva’s Copaxone. related news PC Jeweller up 5%; Motilal Oswal initiates buy, sees 36% upside on strong earnings growth hope Market Update: …


Welcome Close Up, Close-Up Internacional, ims data pharma.#Ims #data #pharma

Posted On Jan 17 2018 by

Prescription More than 120 Information and essential Exclusive services technology More than 650 Developer of the first business Business Analyzer® Arbitration due to a breach in an agreement by IMS Health Launch of Business Analyzer ® Audits This is a solution that effectively measures the prescription results of a promotional effort, by systematically investigating the behavior of markets, therapeutic classes, molecules, products, laboratories and their trends. Targeting enables us to choose Prescribers by therapeutic market in order to target promotional activities on physicians and track the results. It enables users to measure productivity by region (District Manager and Representatives), according …


Aspen Pharmacare, ims data pharma.#Ims #data #pharma

Posted On Jan 17 2018 by

ABOUT ASPEN Aspen has a market capitalisation of approximately US$10 billion, is the largest pharmaceutical company listed on the JSE Limited (share code: APN) and ranks among the top 20 listed companies on this exchange. Investor overview Sustainability documents Aspen increases revenue 16% to R41.2 bn Partnering with the South African Department of Health to Enhance Public Healthcare INVESTOR CALENDAR Financial year end Year end results announcement and presentation in Johannesburg Click here for the results presentation Year end results – Cape Town Annual financial statements for 2017 year end published Annual General Meeting LATEST RESULTS Aspen 2017 Integrated Report …